202 related articles for article (PubMed ID: 17688972)
1. The role of alpha-adrenoreceptors in the treatment of urological diseases.
Romics I
Neurochem Int; 2007 Oct; 51(5):328-31. PubMed ID: 17688972
[TBL] [Abstract][Full Text] [Related]
2. The role of combination medical therapy in benign prostatic hyperplasia.
Greco KA; McVary KT
Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
[TBL] [Abstract][Full Text] [Related]
3. [Medical therapy of benign prostatic hyperplasia].
Altarac S
Lijec Vjesn; 2005; 127(11-12):316-23. PubMed ID: 16583940
[TBL] [Abstract][Full Text] [Related]
4. [Drug therapy for benign prostatic syndrome (BPS)].
Berges R
Aktuelle Urol; 2006 Sep; 37(5):351-62. PubMed ID: 17004180
[TBL] [Abstract][Full Text] [Related]
5. [The use of alpha-receptor blockers in urological diseases].
Heimbach D; Frohmüller H
Dtsch Med Wochenschr; 1992 May; 117(21):825-8. PubMed ID: 1375139
[No Abstract] [Full Text] [Related]
6. Medical management of benign prostatic hypertrophy.
Nix JW; Carson CC
Can J Urol; 2007 Dec; 14 Suppl 1():53-7. PubMed ID: 18163946
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and management of benign prostatic hyperplasia.
Edwards JL
Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology for common urologic diseases: 2011 review for the primary care physician.
Liu XS; Folia C; Gomella LG
Can J Urol; 2011 Apr; 18 Suppl():24-38. PubMed ID: 21501548
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive medical therapy with an alpha-1A-specific blocker after shock wave lithotripsy of lower ureteral stones.
Wang CJ; Huang SW; Chang CH
Urol Int; 2009; 82(2):166-9. PubMed ID: 19322003
[TBL] [Abstract][Full Text] [Related]
10. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.
Roehrborn CG
BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681
[TBL] [Abstract][Full Text] [Related]
11. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
[TBL] [Abstract][Full Text] [Related]
12. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: who are the high-risk patients and what are the best treatment options?
Robert G; Descazeaud A; de la Taille A
Curr Opin Urol; 2011 Jan; 21(1):42-8. PubMed ID: 21045706
[TBL] [Abstract][Full Text] [Related]
13. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
[TBL] [Abstract][Full Text] [Related]
14. (Arylpiperazinyl)cyclohexylsufonamides: discovery of alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms (BPH/LUTS).
Chiu G; Li S; Connolly PJ; Pulito V; Liu J; Middleton SA
Bioorg Med Chem Lett; 2007 Jun; 17(12):3292-7. PubMed ID: 17452102
[TBL] [Abstract][Full Text] [Related]
15. Use of sympathetic alpha antagonists in the management of pediatric urologic disorders.
Husmann DA
Curr Opin Urol; 2006 Jul; 16(4):277-82. PubMed ID: 16770128
[TBL] [Abstract][Full Text] [Related]
16. Contemporary patients with LUTS/BPH requiring prostatectomy have long-term history of treatment with alpha1-blockers and large prostates compared with past cases.
Takeuchi M; Masumori N; Tsukamoto T
Urology; 2009 Sep; 74(3):606-9. PubMed ID: 19586655
[TBL] [Abstract][Full Text] [Related]
17. The long-term outcome of medical therapy for BPH.
Madersbacher S; Marszalek M; Lackner J; Berger P; Schatzl G
Eur Urol; 2007 Jun; 51(6):1522-33. PubMed ID: 17416456
[TBL] [Abstract][Full Text] [Related]
18. Common approach to managing lower urinary tract symptoms and erectile dysfunction.
Taylor JM; Desouza R; Wang R
Asian J Androl; 2008 Jan; 10(1):45-53. PubMed ID: 18087643
[TBL] [Abstract][Full Text] [Related]
19. Prostatic alpha adrenoceptors.
Lepor H; Shapiro E
Prog Clin Biol Res; 1994; 386():271-7. PubMed ID: 7528394
[No Abstract] [Full Text] [Related]
20. [Current trends in the treatment of urological patients with transplanted kidney].
Trapeznikova MF; Urenkov SB; Zubrilina NM; Podoĭnitsyn AA
Urologiia; 2009; (2):9-13. PubMed ID: 19526868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
